Public annual accounts

PHARMACIE VAN TOMME financials

Name: PHARMACIE VAN TOMME financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for PHARMACIE VAN TOMME, with comparable measures and links to available source documents.

Company overview

Registry number

0474416211

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 28, 2026

Financial evidence

Latest movements for PHARMACIE VAN TOMME

2025 versus 2024

Operating line: €164,621
EBITDA: €109,834
Total assets: €983,713
Equity: €410,175

EBITDA margin +66.7% · Equity ratio +41.7%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202531 Dec 2025	€164,621	€109,834	€983,713	€410,175	-
202431 Dec 2024	€151,938	€106,513	€990,202	€419,540	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report